• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性乙型肝炎感染在肝病进展和癌变中的临床意义。

Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.

机构信息

Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan.

出版信息

J Cancer. 2013 Jul 11;4(6):473-80. doi: 10.7150/jca.6609. Print 2013.

DOI:10.7150/jca.6609
PMID:23901347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3726709/
Abstract

Occult hepatitis B infection (OBI) is defined as long-lasting persistence of hepatitis B virus (HBV) DNA in the liver of patients with hepatitis B surface antigen (HBsAg)-negative status, with or without serological markers of previous exposure (antibodies to HBsAg and/or to hepatitis B core antigen). Over the past two decades, significant progress has been made in understanding OBI and its clinical implications. OBI as a cause of chronic liver disease in patients with HBsAg-negative status is becoming an important disease entity. In conditions of immunocompetence, OBI is inoffensive in itself and detection of HBV DNA in the liver does not always indicate active hepatitis. However, when other factors that cause liver damage, such as hepatitis C virus infection, obesity and alcohol abuse are present, the minimal lesions produced by the immunological response to OBI might worsen the clinical course of the underlying liver disease. Several lines of evidence suggest that OBI is associated with progression of liver fibrosis and the development of hepatocellular carcinoma in patients with chronic liver disease. The major interest in OBI is primarily associated with the growing, widely discussed evidence of its clinical impact. The aim of this review is to highlight recent data for OBI, with a major focus on disease progression or carcinogenesis in patients with chronic liver disease.

摘要

隐匿性乙型肝炎病毒感染(OBI)定义为乙型肝炎表面抗原(HBsAg)阴性状态患者肝脏中乙型肝炎病毒(HBV)DNA 的长期持续存在,无论是否存在先前接触的血清学标志物(抗 HBsAg 和/或抗乙型肝炎核心抗原抗体)。在过去的二十年中,人们对 OBI 及其临床意义有了更深入的了解。OBI 作为 HBsAg 阴性状态患者慢性肝病的病因,正成为一种重要的疾病实体。在免疫功能正常的情况下,OBI 本身并无危害,肝脏中检测到 HBV DNA 并不总是表明存在活动性肝炎。然而,当存在其他导致肝损伤的因素,如丙型肝炎病毒感染、肥胖和酗酒时,对 OBI 的免疫反应产生的微小病变可能会使潜在肝病的临床病程恶化。有几条证据表明,OBI 与慢性肝病患者的肝纤维化进展和肝细胞癌的发生有关。人们对 OBI 的主要兴趣主要与日益增多的、广泛讨论的其临床影响的证据有关。本综述的目的是强调 OBI 的最新数据,主要关注慢性肝病患者的疾病进展或癌变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3726709/ab174ab1d3be/jcav04p0473g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3726709/ab174ab1d3be/jcav04p0473g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3726709/ab174ab1d3be/jcav04p0473g01.jpg

相似文献

1
Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis.隐匿性乙型肝炎感染在肝病进展和癌变中的临床意义。
J Cancer. 2013 Jul 11;4(6):473-80. doi: 10.7150/jca.6609. Print 2013.
2
Management of occult hepatitis B virus infection: an update for the clinician.隐匿性乙型肝炎病毒感染的管理:临床医生的最新进展。
World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12.1563.
3
An overview of occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染概述。
World J Gastroenterol. 2011 Apr 21;17(15):1927-38. doi: 10.3748/wjg.v17.i15.1927.
4
Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.隐匿性乙型肝炎病毒感染对慢性丙型肝炎结局的影响。
J Hepatol. 2013 Oct;59(4):696-700. doi: 10.1016/j.jhep.2013.05.043. Epub 2013 Jun 7.
5
Occult hepatitis B virus infection in patients with chronic hepatitis C treated with antiviral therapy.接受抗病毒治疗的慢性丙型肝炎患者中的隐匿性乙型肝炎病毒感染
Hepat Mon. 2012 Nov;12(11):e7292. doi: 10.5812/hepatmon.7292. Epub 2012 Nov 30.
6
Pathogenesis of occult chronic hepatitis B virus infection.隐匿性慢性乙型肝炎病毒感染的发病机制。
World J Gastroenterol. 2011 Mar 28;17(12):1543-8. doi: 10.3748/wjg.v17.i12.1543.
7
Role of occult hepatitis B virus infection in chronic hepatitis C.隐匿性乙型肝炎病毒感染在慢性丙型肝炎中的作用。
World J Gastroenterol. 2015 Nov 14;21(42):11931-40. doi: 10.3748/wjg.v21.i42.11931.
8
Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.丙型肝炎病毒相关性肝细胞癌中隐匿性乙型肝炎病毒感染的临床病理研究
Eur J Gastroenterol Hepatol. 2019 Jun;31(6):716-722. doi: 10.1097/MEG.0000000000001388.
9
Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.日本肝癌患者中隐匿性乙型肝炎感染的频率和特征。
Ann Hepatol. 2018;17(4):596-603. doi: 10.5604/01.3001.0012.0927.
10
HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.乙肝表面抗原阴性的乙型肝炎病毒感染与肝细胞癌
Discov Med. 2014 Oct;18(99):189-93.

引用本文的文献

1
Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis.埃及隐匿性乙型肝炎病毒感染的患病率:一项荟萃分析的系统评价
J Egypt Public Health Assoc. 2023 Jul 26;98(1):13. doi: 10.1186/s42506-023-00138-4.
2
Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia.埃塞俄比亚南部隐匿性乙型肝炎病毒感染及其隐匿传播风险
Infect Drug Resist. 2022 Feb 24;15:619-630. doi: 10.2147/IDR.S344668. eCollection 2022.
3
Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients.

本文引用的文献

1
Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.乙型肝炎核心抗原抗体与非乙型非丙型肝细胞癌治愈性治疗后生存的关系。
Anticancer Res. 2013 May;33(5):2211-9.
2
Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.乙型肝炎核心抗原抗体与丙型肝炎病毒相关肝细胞癌手术后生存无相关性。
Oncol Rep. 2013 Jul;30(1):91-8. doi: 10.3892/or.2013.2422. Epub 2013 Apr 24.
3
Occult hepatitis B: clinical viewpoint and management.
隐匿性乙型肝炎病毒感染慢性丙型肝炎患者的细胞因子谱。
Virol J. 2021 Jan 12;18(1):15. doi: 10.1186/s12985-021-01487-2.
4
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers.通过高灵敏度分子检测,在抗-HBc阳性/HBsAg阴性的HIV感染患者中经常发现隐匿性HBV复制活性,并且可以通过整合经典和新型血清学HBV标志物来预测。
Microorganisms. 2020 Nov 18;8(11):1819. doi: 10.3390/microorganisms8111819.
5
The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.供体与受体乙肝血清流行病学的匹配状态对肝细胞癌肝移植有影响。
Clin Transl Gastroenterol. 2020 May;11(5):e00168. doi: 10.14309/ctg.0000000000000168.
6
Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.隐匿性乙型肝炎病毒感染患者中新型乙型肝炎病毒前S/S基因变异的特征分析
PLoS One. 2016 May 16;11(5):e0155654. doi: 10.1371/journal.pone.0155654. eCollection 2016.
7
Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of iran.伊朗西南部隐源性肝硬化患者中的隐匿性乙型肝炎感染
Jundishapur J Microbiol. 2015 Mar 21;8(3):e16873. doi: 10.5812/jjm.16873. eCollection 2015 Mar.
隐匿性乙型肝炎:临床观点与管理
Hepat Res Treat. 2013;2013:259148. doi: 10.1155/2013/259148. Epub 2013 Mar 4.
4
Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study.在日本一个高度流行地区,乙型肝炎核心抗原抗体对丙型肝炎病毒携带者临床病程的影响:一项基于社区的队列研究。
Hepatol Res. 2013 Nov;43(11):1130-8. doi: 10.1111/hepr.12075. Epub 2013 Feb 18.
5
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.经导管动脉化疗栓塞术在肝癌手术切除前的作用。
Int J Oncol. 2013 Jan;42(1):151-60. doi: 10.3892/ijo.2012.1711. Epub 2012 Nov 21.
6
Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis.乙型肝炎病毒状态与胰腺癌风险:荟萃分析。
Eur J Cancer Prev. 2013 Jul;22(4):328-34. doi: 10.1097/CEJ.0b013e32835b6a21.
7
Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis.隐匿性乙型肝炎病毒与慢性肝病风险:荟萃分析。
Dig Liver Dis. 2013 Mar;45(3):238-44. doi: 10.1016/j.dld.2012.09.021. Epub 2012 Nov 10.
8
Occult Hepatitis B (OBH) in Clinical Settings.临床环境中的隐匿性乙型肝炎(OBH)
Hepat Mon. 2012 Aug;12(8):e6126. doi: 10.5812/hepatmon.6126. Epub 2012 Aug 25.
9
Occult HBV infection.隐匿性乙型肝炎病毒感染。
Semin Immunopathol. 2013 Jan;35(1):39-52. doi: 10.1007/s00281-012-0327-7. Epub 2012 Jul 26.
10
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.抗病毒治疗预防乙型肝炎病毒相关肝细胞癌。
Hepatology. 2013 Jan;57(1):399-408. doi: 10.1002/hep.25937.